当前位置: X-MOL 学术BBA Gen. Subj. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
O-linked N-acetylgalactosamine modification is present on the tumor suppressor p53.
Biochimica et Biophysica Acta (BBA) - General Subjects ( IF 3 ) Pub Date : 2020-05-14 , DOI: 10.1016/j.bbagen.2020.129635
Zhijue Xu 1 , Xin Ku 1 , Azusa Tomioka 2 , Wenxian Xie 1 , Tao Liang 1 , Xia Zou 1 , Yalu Cui 1 , Takashi Sato 2 , Hiroyuki Kaji 2 , Hisashi Narimatsu 3 , Wei Yan 1 , Yan Zhang 4
Affiliation  

BACKGROUND Mucin-type O-glycosylation (referred to as O-GalNAc glycosylation) is the most abundant O-glycosylation on membrane and secretory proteins. Recently several evidences suggest that nuclear or cytoplasmic proteins might also have O-GalNAc glycosylation. However, what nucleocytoplasmic proteins are O-GalNAc glycosylated and what the biological function of this modification in cells are still poorly understood. Previously, we reported the tumor suppressor p53 could be O-GalNAc glycosylated in vitro. To investigate the existence and function of O-GalNAc glycosylation on nucleocytoplasmic proteins in cell, p53 as a representative nucleocytoplasmic protein was studied. METHODS Using lectin blotting with GalNAc specific lectins, enzymatic treatments with O-GlcNAcase, core 1 β1, 3-galactosyltransferase and O-glycosidase, and metabolic labeling with un-O-acetylated GalNAz in UDP-Gal/UDP-GalNAc 4-epimerase (GALE) knockout cells, we validated the O-GalNAc glycosylation on p53. Using mass spectrometry analysis and site-directed mutagenesis, we identified the glycosylated sites and studied the functions of O-GalNAc glycosylation on p53. RESULTS The p53 was O-GalNAc glycosylated in cells. Ser121 residue was one of the glycosylated sites on p53. The O-GalNAc glycosylation at Ser121 was associated with the stability and activity of p53. CONCLUSIONS These results revealed that the O-GalNAc glycosylation was a novel modification on p53. GENERAL SIGNIFICANCE Our study provided a pilot evidence that the O-GalNAc glycosylation existed on nucleocytoplasmic protein.

中文翻译:

O-联的N-乙酰半乳糖胺修饰存在于肿瘤抑制因子p53上。

背景技术粘蛋白型O-糖基化(称为O-GalNAc糖基化)是膜和分泌蛋白上最丰富的O-糖基化。最近,一些证据表明核蛋白或胞质蛋白也可能具有O-GalNAc糖基化作用。然而,仍然不清楚O-GalNAc被糖基化的是什么胞质蛋白,以及这种修饰在细胞中的生物学功能是什么。以前,我们报道肿瘤抑制因子p53可能在体外被O-GalNAc糖基化。为了研究O-GalNAc糖基化在细胞核蛋白上的存在和功能,研究了以p53为代表的核蛋白。方法:使用GalNAc特异性凝集素进行凝集素印迹,用O-GlcNAcase,核心1 β1、3-半乳糖基转移酶和O-糖苷酶进行酶处理,并在敲除UDP-Gal / UDP-GalNAc 4-表异构酶(GALE)的细胞中用非O-乙酰化GalNAz进行代谢标记,我们验证了p53上的O-GalNAc糖基化。使用质谱分析和定点诱变,我们确定了糖基化的位点,并研究了O-GalNAc糖基化对p53的功能。结果p53在细胞中被O-GalNAc糖基化。Ser121残基是p53上糖基化的位点之一。Ser121处的O-GalNAc糖基化与p53的稳定性和活性有关。结论这些结果表明,O-GalNAc糖基化是对p53的新修饰。一般意义我们的研究提供了一个初步证据,表明核质蛋白上存在O-GalNAc糖基化。我们验证了p53的O-GalNAc糖基化。使用质谱分析和定点诱变,我们确定了糖基化的位点,并研究了O-GalNAc糖基化对p53的功能。结果p53在细胞中被O-GalNAc糖基化。Ser121残基是p53上糖基化的位点之一。Ser121处的O-GalNAc糖基化与p53的稳定性和活性有关。结论这些结果表明,O-GalNAc糖基化是对p53的新修饰。一般意义我们的研究提供了一个初步证据,表明核质蛋白上存在O-GalNAc糖基化。我们验证了p53上的O-GalNAc糖基化。使用质谱分析和定点诱变,我们确定了糖基化的位点,并研究了O-GalNAc糖基化对p53的功能。结果p53在细胞中被O-GalNAc糖基化。Ser121残基是p53上糖基化的位点之一。Ser121处的O-GalNAc糖基化与p53的稳定性和活性有关。结论这些结果表明,O-GalNAc糖基化是对p53的新修饰。一般意义我们的研究提供了一个初步证据,表明核质蛋白上存在O-GalNAc糖基化。结果p53在细胞中被O-GalNAc糖基化。Ser121残基是p53上糖基化的位点之一。Ser121处的O-GalNAc糖基化与p53的稳定性和活性有关。结论这些结果表明,O-GalNAc糖基化是对p53的新修饰。一般意义我们的研究提供了一个初步证据,表明核质蛋白上存在O-GalNAc糖基化。结果p53在细胞中被O-GalNAc糖基化。Ser121残基是p53上糖基化的位点之一。Ser121处的O-GalNAc糖基化与p53的稳定性和活性有关。结论这些结果表明,O-GalNAc糖基化是对p53的新修饰。一般意义我们的研究提供了一个初步证据,表明核质蛋白上存在O-GalNAc糖基化。
更新日期:2020-05-14
down
wechat
bug